Hormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctions

The regeneration potential of implantable organ model hydrogels is applied to treat a loss of ovarian endocrine function in women experiencing menopause and/or cancer therapy. A rat ovariectomy model is used to harvest autologous ovary cells while subsequently producing a layer-by-layer form of foll...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science advances 2021-04, Vol.7 (18)
Hauptverfasser: Yoon, Hyo-Jin, Lee, Yong Jae, Baek, Sewoom, Chung, Young Shin, Kim, Dae-Hyun, Lee, Jae Hoon, Shin, Yong Cheol, Shin, Young Min, Ryu, Chungsoon, Kim, Hye-Seon, Ahn, So Hyun, Kim, Heeyon, Won, Young Bin, Lee, Inha, Jeon, Myung Jae, Cho, Si Hyun, Lee, Byung Seok, Sung, Hak-Joon, Choi, Young Sik
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 18
container_start_page
container_title Science advances
container_volume 7
creator Yoon, Hyo-Jin
Lee, Yong Jae
Baek, Sewoom
Chung, Young Shin
Kim, Dae-Hyun
Lee, Jae Hoon
Shin, Yong Cheol
Shin, Young Min
Ryu, Chungsoon
Kim, Hye-Seon
Ahn, So Hyun
Kim, Heeyon
Won, Young Bin
Lee, Inha
Jeon, Myung Jae
Cho, Si Hyun
Lee, Byung Seok
Sung, Hak-Joon
Choi, Young Sik
description The regeneration potential of implantable organ model hydrogels is applied to treat a loss of ovarian endocrine function in women experiencing menopause and/or cancer therapy. A rat ovariectomy model is used to harvest autologous ovary cells while subsequently producing a layer-by-layer form of follicle spheroids. Implantation of a microchannel network hydrogel with cell spheroids [vascularized hydrogel with ovarian spheroids (VHOS)] into an ischemic hindlimb of ovariectomized rats significantly aids the recovery of endocrine function with hormone release, leading to full endometrium regeneration. The VHOS implantation effectively suppresses the side effects observed with synthetic hormone treatment (i.e., tissue overgrowth, hyperplasia, cancer progression, deep vein thrombosis) to the normal levels, while effectively preventing the representative aftereffects of menopause (i.e., gaining fatty weight, inducing osteoporosis). These results highlight the unprecedented therapeutic potential of an implantable VHOS against menopause and suggest that it may be used as an alternative approach to standard hormone therapy.
doi_str_mv 10.1126/sciadv.abe8873
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8081364</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2519812834</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-ccbf0df946653c08984569b8bc7c860702c7182338d21b0c0c70b01fc238c7023</originalsourceid><addsrcrecordid>eNpVUU1Lw0AUXESxpfbqUfbopXU_8rG5CFLUCgUvel42bzftSpKtu0kg_noTW6We3sCbmTe8QeiakiWlLLkLYJXulio3QqT8DE0ZT-MFiyNxfoInaB7CByGERkkS0-wSTTjPKBEZmyK7dr5ytcGqbRx4W6vGuhrnPe5UgLZU3n4ZjXe99m5rSqxNaTvje-wK7Do1gLDfGe-sDrhx2JtBZH42VtVY96FoaxgtwxW6KFQZzPw4Z-j96fFttV5sXp9fVg-bBfCMNAuAvCC6yMasHIaQIoqTLBc5pCASkhIGKRWMc6EZzQkQSElOaAGMiwEyPkP3B999m1dGg6kbr0q597Ya4kqnrPy_qe1Obl0nBRGUJ9FgcHs08O6zNaGRlQ1gylLVxrVBsuGHgjLBR-ryQAXvQvCm-DtDiRwrkoeK5LGiQXBzGu6P_lsI_wbZgZIf</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2519812834</pqid></control><display><type>article</type><title>Hormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctions</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Yoon, Hyo-Jin ; Lee, Yong Jae ; Baek, Sewoom ; Chung, Young Shin ; Kim, Dae-Hyun ; Lee, Jae Hoon ; Shin, Yong Cheol ; Shin, Young Min ; Ryu, Chungsoon ; Kim, Hye-Seon ; Ahn, So Hyun ; Kim, Heeyon ; Won, Young Bin ; Lee, Inha ; Jeon, Myung Jae ; Cho, Si Hyun ; Lee, Byung Seok ; Sung, Hak-Joon ; Choi, Young Sik</creator><creatorcontrib>Yoon, Hyo-Jin ; Lee, Yong Jae ; Baek, Sewoom ; Chung, Young Shin ; Kim, Dae-Hyun ; Lee, Jae Hoon ; Shin, Yong Cheol ; Shin, Young Min ; Ryu, Chungsoon ; Kim, Hye-Seon ; Ahn, So Hyun ; Kim, Heeyon ; Won, Young Bin ; Lee, Inha ; Jeon, Myung Jae ; Cho, Si Hyun ; Lee, Byung Seok ; Sung, Hak-Joon ; Choi, Young Sik</creatorcontrib><description>The regeneration potential of implantable organ model hydrogels is applied to treat a loss of ovarian endocrine function in women experiencing menopause and/or cancer therapy. A rat ovariectomy model is used to harvest autologous ovary cells while subsequently producing a layer-by-layer form of follicle spheroids. Implantation of a microchannel network hydrogel with cell spheroids [vascularized hydrogel with ovarian spheroids (VHOS)] into an ischemic hindlimb of ovariectomized rats significantly aids the recovery of endocrine function with hormone release, leading to full endometrium regeneration. The VHOS implantation effectively suppresses the side effects observed with synthetic hormone treatment (i.e., tissue overgrowth, hyperplasia, cancer progression, deep vein thrombosis) to the normal levels, while effectively preventing the representative aftereffects of menopause (i.e., gaining fatty weight, inducing osteoporosis). These results highlight the unprecedented therapeutic potential of an implantable VHOS against menopause and suggest that it may be used as an alternative approach to standard hormone therapy.</description><identifier>ISSN: 2375-2548</identifier><identifier>EISSN: 2375-2548</identifier><identifier>DOI: 10.1126/sciadv.abe8873</identifier><identifier>PMID: 33910892</identifier><language>eng</language><publisher>United States: American Association for the Advancement of Science</publisher><subject>Animals ; Applied Sciences and Engineering ; Cancer ; Female ; Health and Medicine ; Hormones ; Humans ; Hydrogels ; Ovariectomy ; Ovary ; Rats ; SciAdv r-articles ; Spheroids, Cellular</subject><ispartof>Science advances, 2021-04, Vol.7 (18)</ispartof><rights>Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).</rights><rights>Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). 2021 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-ccbf0df946653c08984569b8bc7c860702c7182338d21b0c0c70b01fc238c7023</citedby><cites>FETCH-LOGICAL-c390t-ccbf0df946653c08984569b8bc7c860702c7182338d21b0c0c70b01fc238c7023</cites><orcidid>0000-0002-5965-7205 ; 0000-0002-1196-5452 ; 0000-0003-2061-8169 ; 0000-0003-2312-2484 ; 0000-0003-0297-3116 ; 0000-0002-8757-4634 ; 0000-0002-8818-454X ; 0000-0002-1418-5929 ; 0000-0002-7345-7090 ; 0000-0002-3128-8815 ; 0000-0002-3525-3812 ; 0000-0001-5582-1488 ; 0000-0003-2718-6645 ; 0000-0003-4869-6281 ; 0000-0002-6107-5837</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081364/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081364/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33910892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yoon, Hyo-Jin</creatorcontrib><creatorcontrib>Lee, Yong Jae</creatorcontrib><creatorcontrib>Baek, Sewoom</creatorcontrib><creatorcontrib>Chung, Young Shin</creatorcontrib><creatorcontrib>Kim, Dae-Hyun</creatorcontrib><creatorcontrib>Lee, Jae Hoon</creatorcontrib><creatorcontrib>Shin, Yong Cheol</creatorcontrib><creatorcontrib>Shin, Young Min</creatorcontrib><creatorcontrib>Ryu, Chungsoon</creatorcontrib><creatorcontrib>Kim, Hye-Seon</creatorcontrib><creatorcontrib>Ahn, So Hyun</creatorcontrib><creatorcontrib>Kim, Heeyon</creatorcontrib><creatorcontrib>Won, Young Bin</creatorcontrib><creatorcontrib>Lee, Inha</creatorcontrib><creatorcontrib>Jeon, Myung Jae</creatorcontrib><creatorcontrib>Cho, Si Hyun</creatorcontrib><creatorcontrib>Lee, Byung Seok</creatorcontrib><creatorcontrib>Sung, Hak-Joon</creatorcontrib><creatorcontrib>Choi, Young Sik</creatorcontrib><title>Hormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctions</title><title>Science advances</title><addtitle>Sci Adv</addtitle><description>The regeneration potential of implantable organ model hydrogels is applied to treat a loss of ovarian endocrine function in women experiencing menopause and/or cancer therapy. A rat ovariectomy model is used to harvest autologous ovary cells while subsequently producing a layer-by-layer form of follicle spheroids. Implantation of a microchannel network hydrogel with cell spheroids [vascularized hydrogel with ovarian spheroids (VHOS)] into an ischemic hindlimb of ovariectomized rats significantly aids the recovery of endocrine function with hormone release, leading to full endometrium regeneration. The VHOS implantation effectively suppresses the side effects observed with synthetic hormone treatment (i.e., tissue overgrowth, hyperplasia, cancer progression, deep vein thrombosis) to the normal levels, while effectively preventing the representative aftereffects of menopause (i.e., gaining fatty weight, inducing osteoporosis). These results highlight the unprecedented therapeutic potential of an implantable VHOS against menopause and suggest that it may be used as an alternative approach to standard hormone therapy.</description><subject>Animals</subject><subject>Applied Sciences and Engineering</subject><subject>Cancer</subject><subject>Female</subject><subject>Health and Medicine</subject><subject>Hormones</subject><subject>Humans</subject><subject>Hydrogels</subject><subject>Ovariectomy</subject><subject>Ovary</subject><subject>Rats</subject><subject>SciAdv r-articles</subject><subject>Spheroids, Cellular</subject><issn>2375-2548</issn><issn>2375-2548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUU1Lw0AUXESxpfbqUfbopXU_8rG5CFLUCgUvel42bzftSpKtu0kg_noTW6We3sCbmTe8QeiakiWlLLkLYJXulio3QqT8DE0ZT-MFiyNxfoInaB7CByGERkkS0-wSTTjPKBEZmyK7dr5ytcGqbRx4W6vGuhrnPe5UgLZU3n4ZjXe99m5rSqxNaTvje-wK7Do1gLDfGe-sDrhx2JtBZH42VtVY96FoaxgtwxW6KFQZzPw4Z-j96fFttV5sXp9fVg-bBfCMNAuAvCC6yMasHIaQIoqTLBc5pCASkhIGKRWMc6EZzQkQSElOaAGMiwEyPkP3B999m1dGg6kbr0q597Ya4kqnrPy_qe1Obl0nBRGUJ9FgcHs08O6zNaGRlQ1gylLVxrVBsuGHgjLBR-ryQAXvQvCm-DtDiRwrkoeK5LGiQXBzGu6P_lsI_wbZgZIf</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Yoon, Hyo-Jin</creator><creator>Lee, Yong Jae</creator><creator>Baek, Sewoom</creator><creator>Chung, Young Shin</creator><creator>Kim, Dae-Hyun</creator><creator>Lee, Jae Hoon</creator><creator>Shin, Yong Cheol</creator><creator>Shin, Young Min</creator><creator>Ryu, Chungsoon</creator><creator>Kim, Hye-Seon</creator><creator>Ahn, So Hyun</creator><creator>Kim, Heeyon</creator><creator>Won, Young Bin</creator><creator>Lee, Inha</creator><creator>Jeon, Myung Jae</creator><creator>Cho, Si Hyun</creator><creator>Lee, Byung Seok</creator><creator>Sung, Hak-Joon</creator><creator>Choi, Young Sik</creator><general>American Association for the Advancement of Science</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5965-7205</orcidid><orcidid>https://orcid.org/0000-0002-1196-5452</orcidid><orcidid>https://orcid.org/0000-0003-2061-8169</orcidid><orcidid>https://orcid.org/0000-0003-2312-2484</orcidid><orcidid>https://orcid.org/0000-0003-0297-3116</orcidid><orcidid>https://orcid.org/0000-0002-8757-4634</orcidid><orcidid>https://orcid.org/0000-0002-8818-454X</orcidid><orcidid>https://orcid.org/0000-0002-1418-5929</orcidid><orcidid>https://orcid.org/0000-0002-7345-7090</orcidid><orcidid>https://orcid.org/0000-0002-3128-8815</orcidid><orcidid>https://orcid.org/0000-0002-3525-3812</orcidid><orcidid>https://orcid.org/0000-0001-5582-1488</orcidid><orcidid>https://orcid.org/0000-0003-2718-6645</orcidid><orcidid>https://orcid.org/0000-0003-4869-6281</orcidid><orcidid>https://orcid.org/0000-0002-6107-5837</orcidid></search><sort><creationdate>20210401</creationdate><title>Hormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctions</title><author>Yoon, Hyo-Jin ; Lee, Yong Jae ; Baek, Sewoom ; Chung, Young Shin ; Kim, Dae-Hyun ; Lee, Jae Hoon ; Shin, Yong Cheol ; Shin, Young Min ; Ryu, Chungsoon ; Kim, Hye-Seon ; Ahn, So Hyun ; Kim, Heeyon ; Won, Young Bin ; Lee, Inha ; Jeon, Myung Jae ; Cho, Si Hyun ; Lee, Byung Seok ; Sung, Hak-Joon ; Choi, Young Sik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-ccbf0df946653c08984569b8bc7c860702c7182338d21b0c0c70b01fc238c7023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Applied Sciences and Engineering</topic><topic>Cancer</topic><topic>Female</topic><topic>Health and Medicine</topic><topic>Hormones</topic><topic>Humans</topic><topic>Hydrogels</topic><topic>Ovariectomy</topic><topic>Ovary</topic><topic>Rats</topic><topic>SciAdv r-articles</topic><topic>Spheroids, Cellular</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yoon, Hyo-Jin</creatorcontrib><creatorcontrib>Lee, Yong Jae</creatorcontrib><creatorcontrib>Baek, Sewoom</creatorcontrib><creatorcontrib>Chung, Young Shin</creatorcontrib><creatorcontrib>Kim, Dae-Hyun</creatorcontrib><creatorcontrib>Lee, Jae Hoon</creatorcontrib><creatorcontrib>Shin, Yong Cheol</creatorcontrib><creatorcontrib>Shin, Young Min</creatorcontrib><creatorcontrib>Ryu, Chungsoon</creatorcontrib><creatorcontrib>Kim, Hye-Seon</creatorcontrib><creatorcontrib>Ahn, So Hyun</creatorcontrib><creatorcontrib>Kim, Heeyon</creatorcontrib><creatorcontrib>Won, Young Bin</creatorcontrib><creatorcontrib>Lee, Inha</creatorcontrib><creatorcontrib>Jeon, Myung Jae</creatorcontrib><creatorcontrib>Cho, Si Hyun</creatorcontrib><creatorcontrib>Lee, Byung Seok</creatorcontrib><creatorcontrib>Sung, Hak-Joon</creatorcontrib><creatorcontrib>Choi, Young Sik</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Science advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoon, Hyo-Jin</au><au>Lee, Yong Jae</au><au>Baek, Sewoom</au><au>Chung, Young Shin</au><au>Kim, Dae-Hyun</au><au>Lee, Jae Hoon</au><au>Shin, Yong Cheol</au><au>Shin, Young Min</au><au>Ryu, Chungsoon</au><au>Kim, Hye-Seon</au><au>Ahn, So Hyun</au><au>Kim, Heeyon</au><au>Won, Young Bin</au><au>Lee, Inha</au><au>Jeon, Myung Jae</au><au>Cho, Si Hyun</au><au>Lee, Byung Seok</au><au>Sung, Hak-Joon</au><au>Choi, Young Sik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctions</atitle><jtitle>Science advances</jtitle><addtitle>Sci Adv</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>7</volume><issue>18</issue><issn>2375-2548</issn><eissn>2375-2548</eissn><abstract>The regeneration potential of implantable organ model hydrogels is applied to treat a loss of ovarian endocrine function in women experiencing menopause and/or cancer therapy. A rat ovariectomy model is used to harvest autologous ovary cells while subsequently producing a layer-by-layer form of follicle spheroids. Implantation of a microchannel network hydrogel with cell spheroids [vascularized hydrogel with ovarian spheroids (VHOS)] into an ischemic hindlimb of ovariectomized rats significantly aids the recovery of endocrine function with hormone release, leading to full endometrium regeneration. The VHOS implantation effectively suppresses the side effects observed with synthetic hormone treatment (i.e., tissue overgrowth, hyperplasia, cancer progression, deep vein thrombosis) to the normal levels, while effectively preventing the representative aftereffects of menopause (i.e., gaining fatty weight, inducing osteoporosis). These results highlight the unprecedented therapeutic potential of an implantable VHOS against menopause and suggest that it may be used as an alternative approach to standard hormone therapy.</abstract><cop>United States</cop><pub>American Association for the Advancement of Science</pub><pmid>33910892</pmid><doi>10.1126/sciadv.abe8873</doi><orcidid>https://orcid.org/0000-0002-5965-7205</orcidid><orcidid>https://orcid.org/0000-0002-1196-5452</orcidid><orcidid>https://orcid.org/0000-0003-2061-8169</orcidid><orcidid>https://orcid.org/0000-0003-2312-2484</orcidid><orcidid>https://orcid.org/0000-0003-0297-3116</orcidid><orcidid>https://orcid.org/0000-0002-8757-4634</orcidid><orcidid>https://orcid.org/0000-0002-8818-454X</orcidid><orcidid>https://orcid.org/0000-0002-1418-5929</orcidid><orcidid>https://orcid.org/0000-0002-7345-7090</orcidid><orcidid>https://orcid.org/0000-0002-3128-8815</orcidid><orcidid>https://orcid.org/0000-0002-3525-3812</orcidid><orcidid>https://orcid.org/0000-0001-5582-1488</orcidid><orcidid>https://orcid.org/0000-0003-2718-6645</orcidid><orcidid>https://orcid.org/0000-0003-4869-6281</orcidid><orcidid>https://orcid.org/0000-0002-6107-5837</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2375-2548
ispartof Science advances, 2021-04, Vol.7 (18)
issn 2375-2548
2375-2548
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8081364
source MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Animals
Applied Sciences and Engineering
Cancer
Female
Health and Medicine
Hormones
Humans
Hydrogels
Ovariectomy
Ovary
Rats
SciAdv r-articles
Spheroids, Cellular
title Hormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T00%3A35%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hormone%20autocrination%20by%20vascularized%20hydrogel%20delivery%20of%20ovary%20spheroids%20to%20rescue%20ovarian%20dysfunctions&rft.jtitle=Science%20advances&rft.au=Yoon,%20Hyo-Jin&rft.date=2021-04-01&rft.volume=7&rft.issue=18&rft.issn=2375-2548&rft.eissn=2375-2548&rft_id=info:doi/10.1126/sciadv.abe8873&rft_dat=%3Cproquest_pubme%3E2519812834%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2519812834&rft_id=info:pmid/33910892&rfr_iscdi=true